Clinical Trials Directory

Trials / Completed

CompletedNCT03162965

Innovations in HIV Testing

Innovations in HIV Testing to Enhance Care for Young Women and Their Peers and Partners

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
898 (actual)
Sponsor
University of North Carolina, Chapel Hill · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care.

Detailed description

The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care. In this study the investigators proposed two phases. The first phase, previously completed, is formative and involved two parts: 1) conducting formative qualitative research to understand perceptions of HIV testing and HIV self-testing in the study population and 2) conducting observed HIV self-testing to better understand any challenges with self-testing and the materials needed to make the process clear. The second phase of the study is a randomized controlled trial where the investigators will randomize approximately 400 young women to receive either 1) CHOICE of self-testing or clinic-based HIV Counseling and Testing (HCT) or 2) clinic based HCT. Once young women have been randomized, they will be asked to recruit up to 4 peers or male sex partners to test with the method of their randomization group.

Conditions

Interventions

TypeNameDescription
OTHEROraquick HIV Self TestThis is an oral swab in home HIV test.
OTHERClinic Based HIV Counseling and Testing (HCT)Receiving Counseling and Testing for HIV at the clinic.

Timeline

Start date
2016-12-01
Primary completion
2018-10-31
Completion
2018-10-31
First posted
2017-05-22
Last updated
2019-08-09

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT03162965. Inclusion in this directory is not an endorsement.